Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase 4 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01617824
What this trial is testing

Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesChronic Renal Failure
University of Padova 45
Post-approval studies (Phase 4)UnknownNCT00699322
What this trial is testing

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

Who this might be right for
Type 2 Diabetes
The Catholic University of Korea 36
Testing effectiveness (Phase 2)Ended earlyNCT01101945
What this trial is testing

Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Phenomix 339
Post-approval studies (Phase 4)Study completedNCT02741687
What this trial is testing

Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

Who this might be right for
Hyperglycemia
Emory University 80
Not applicableStudy completedNCT03764631
What this trial is testing

Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,502
Not applicableStudy completedNCT04061473
What this trial is testing

Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion

Who this might be right for
Diabetes After Total Pancreatectomy
University Hospital, Gentofte, Copenhagen 20
Not applicableStudy completedNCT04735042
What this trial is testing

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.

Who this might be right for
Type 2 DiabetesUrinary Tract Infections
University of Pisa 60
Post-approval studies (Phase 4)Study completedNCT03770052
What this trial is testing

Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie

Who this might be right for
Type 2 Diabetes MellitusInadequate Glucose Control
Pusan National University Hospital 159
Not applicableUnknownNCT05429554
What this trial is testing

The Effect of Metformin and DPP4 Inhibitors on Cognition and Cardiovascular Protection in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
MTI University 60
Post-approval studies (Phase 4)Study completedNCT03178591
What this trial is testing

Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor

Who this might be right for
Diabetes Mellitus, Type 2Ischemic Heart Disease
Chiang Mai University 43
Large-scale testing (Phase 3)Study completedNCT00661362
What this trial is testing

Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 570
Post-approval studies (Phase 4)Study completedNCT01378117
What this trial is testing

Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusHospitalizationHyperglycemia
Emory University 90
Not applicableStudy completedNCT02186080
What this trial is testing

Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia

Who this might be right for
Type 2 Diabetes Mellitus
Seoul National University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT03751657
What this trial is testing

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 247
Not applicableStudy completedNCT04304430
What this trial is testing

Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors

Who this might be right for
Type 2 Diabetes
University of Padova 11,206
Post-approval studies (Phase 4)Study completedNCT03122041
What this trial is testing

Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome

Who this might be right for
PCOS
University Medical Centre Ljubljana 30
Large-scale testing (Phase 3)Study completedNCT01937598
What this trial is testing

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

Who this might be right for
Type 2 Diabetes
Michael A. Nauck 16
Post-approval studies (Phase 4)Study completedNCT03231709
What this trial is testing

Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 60
Not applicableActive Not RecruitingNCT06611904
What this trial is testing

The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria

Who this might be right for
Urine Albumin (UAlb)GlycocalyxArterial Stiffness
Attikon Hospital 60
Post-approval studies (Phase 4)UnknownNCT02802644
What this trial is testing

The Effect of DPP4 Inhibitor on Vasclular Healing

Who this might be right for
Acute Coronary SyndromeDiabetes Mellitus, Type 2
Chung-Ang University 66
Next Page